CPI-613 may be used to treat clear cell sarcoma, pancreatic, biliary tract cancer

J. Leonard Lichtenfeld joins SpotitEarly as CMO

J. Leonard Lichtenfeld joined SpotitEarly, an Israel-based technology company transforming cancer screening by harnessing the power of artificial intelligence and dogs to detect cancer early, as chief medical officer.

November 15, 2024

Vol.50 No.43

In Brief

Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting

NIH Director Monica M. Bertagnolli delivered the Charles G. Moertel Lecture at the Fall Group Meeting of the Alliance for Clinical Trials in Oncology. The meeting took place Oct. 30-Nov. 1.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Keytruda improves outcomes in soft tissue sarcoma

Addition of the immunotherapy drug pembrolizumab (Keytruda) to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results of the SU2C-SARC032 clinical trial led by researchers from the University of Pittsburgh, UPMC, Duke University, and Princess Margaret Cancer Centre.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results

Promising preliminary results from an ongoing investigator-initiated phase I clinical trial evaluating the safety and efficacy of a combined regimen of Keytrua (pembrolizumab) and Lymphir (denileukin diftitox-cxdl or E7777) in patients with recurrent solid tumors were announced.

November 15, 2024

Vol.50 No.43

In Brief

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

University of Michigan Health Rogel Cancer Center received a $50 million gift from Richard and Susan Rogel for pancreatic cancer research and care.

November 08, 2024

Vol.50 No.42

Clinical Roundup

Survey shows dangerous knowledge gaps in pancreatic cancer

While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows that most people continue to believe that pancreatic disease affects only elderly people—and that there is nothing they can do to...

November 08, 2024

Vol.50 No.42

CPI-613 may be used to treat clear cell sarcoma, pancreatic, biliary tract cancer

YOU MAY BE INTERESTED IN

J. Leonard Lichtenfeld joins SpotitEarly as CMO

Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting

Keytruda improves outcomes in soft tissue sarcoma

Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

Survey shows dangerous knowledge gaps in pancreatic cancer

Renew today!

Subscriber content

Never miss an issue!

Login